Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jennifer Bush

COO, General Counsel at Artiva Biotherapeutics, Inc. (ARTV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $230K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 6SEC ARTVArtiva Biotherapeutics, Inc. Sell 8,370366,159 held (−2%) $6.84 $57K -14.4%
Sep 4SEC ARTVArtiva Biotherapeutics, Inc. Sell 8,391329,529 held (−2%) $11.16 $94K -47.6%
May 19SEC ARTVArtiva Biotherapeutics, Inc. Sell 8,790337,920 held (−3%) $9.01 $79K -35.1%